-- 
Protalix Falls Most in 9 Months on FDA Protein Delay

-- B y   S h o s h a n n a   S o l o m o n
-- 
2011-12-06T15:24:25Z

-- http://www.bloomberg.com/news/2011-12-06/protalix-tumbles-most-in-10-months-on-fda-gaucher-protein-delay.html
(Corrects size of drop in lead, second paragraph.)  Protalix BioTherapeutics Inc. (PLX)  fell
the most in more than nine months after the biotechnology
company said the U.S.  Food and Drug Administration  delayed a
decision on its Gaucher disease protein.  The shares tumbled 21 percent, the most since Feb. 27, to
18.30 shekels at 3:43 p.m. in  Tel Aviv .  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  